Furer, V.; Eviatar, T.; Zisman, D.; Peleg, H.; Braun-Moscovici, Y.; Balbir-Gurman, A.; Paran, D.; Levartovsky, D.; Zisapel, M.; Elalouf, O.;
et al. Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab. Vaccines 2022, 10, 901.
https://doi.org/10.3390/vaccines10060901
AMA Style
Furer V, Eviatar T, Zisman D, Peleg H, Braun-Moscovici Y, Balbir-Gurman A, Paran D, Levartovsky D, Zisapel M, Elalouf O,
et al. Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab. Vaccines. 2022; 10(6):901.
https://doi.org/10.3390/vaccines10060901
Chicago/Turabian Style
Furer, Victoria, Tali Eviatar, Devy Zisman, Hagit Peleg, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf,
and et al. 2022. "Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab" Vaccines 10, no. 6: 901.
https://doi.org/10.3390/vaccines10060901
APA Style
Furer, V., Eviatar, T., Zisman, D., Peleg, H., Braun-Moscovici, Y., Balbir-Gurman, A., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Broyde, A., Polachek, A., Feld, J., Haddad, A., Gazitt, T., Elias, M., Higazi, N., Kharouf, F.,
... Elkayam, O.
(2022). Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab. Vaccines, 10(6), 901.
https://doi.org/10.3390/vaccines10060901
